Published in Clin Neuropharmacol on January 01, 1986
Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 2.42
Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci U S A (1996) 1.78
Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects. Br J Clin Pharmacol (1990) 0.93
Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157. Neuropsychopharmacology (2009) 0.93
Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review. J Psychiatry Neurosci (1992) 0.91
Transdermal selegiline for the treatment of major depressive disorder. Neuropsychiatr Dis Treat (2007) 0.90
Mixed linear and non-linear disposition of lazabemide, a reversible and selective inhibitor of monoamine oxidase B. Br J Clin Pharmacol (1994) 0.82
Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man. Br J Clin Pharmacol (1998) 0.79
Interactions of moclobemide with concomitantly administered medication: evidence from pharmacological and clinical studies. Psychopharmacology (Berl) (1992) 0.77
Monoamine oxidase inhibitors: clinical review. Can Fam Physician (1990) 0.75
Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6. Cell Mol Neurobiol (2004) 0.75
Clinicopathologic correlates in Alzheimer disease: assessment of clinical and pathologic diagnostic criteria. Alzheimer Dis Assoc Disord (1993) 1.80
End-stage Alzheimer's disease. Glasgow Coma Scale and the neurologic examination. Arch Neurol (1993) 1.46
Alzheimer's disease: the problem of incorrect clinical diagnosis. J Geriatr Psychiatry Neurol (1994) 0.77
Increased levels of truncated nerve growth factor receptor in urine of mildly demented patients with Alzheimer's disease. Arch Neurol (1993) 0.76
Behavioral disturbance in severe Alzheimer's disease: a comparison of family member and nursing staff reporting. J Am Geriatr Soc (1992) 0.76
Episodic dyscontrol disorder and paroxysmal EEG abnormalities: successful treatment with carbamazepine. Biol Psychiatry (1986) 0.75
Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 3). Clin Pediatr (Phila) (1986) 0.75
Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 1). Clin Pediatr (Phila) (1986) 0.75
Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 2). Clin Pediatr (Phila) (1986) 0.75